Barclays

Recent news

• Rating change
  Barclays Maintains Cigna Group(CI.US) With Hold Rating, Maintains Target Price $310
  Market Newswire · 2026/10/1
• Barclays: U.S. 30-Year Treasury Yield Could Rise to 6% if Productivity Growth Continues to Accelerate
  Global Market Report · 2026/9/30
• Barclays (BCS.US) has appointed Ramin Naji as Head of Healthcare and Real Estate for the Asia-Pacific region.
  Zhitong Finance · 2026/8/26
• Rating change
  Barclays Maintains PepsiCo(PEP.US) With Hold Rating, Cuts Target Price to $133
  Market Newswire · 2026/10/1
• Rating change
  Barclays Maintains NVIDIA(NVDA.US) With Buy Rating, Maintains Target Price $275
  Market Newswire · 2026/10/1
• Company notice
  Radcom | SC 13G: Statement of acquisition of beneficial ownership by individuals-Barclays PLC(5.72%),Barclays Capital Inc.(5.64%), etc.
  SEC · 2024/2/17
• Company notice
  BARCLAYS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Barclays PLC(5.72%),Barclays Capital Inc.(5.64%), etc.
  SEC · 2024/2/17
• Rating change
  Barclays Maintains FedEx(FDX.US) With Buy Rating, Maintains Target Price $425
  Market Newswire · 2026/10/1
• Rating change
  Barclays Maintains NetApp(NTAP.US) With Buy Rating, Maintains Target Price $219
  Market Newswire · 2026/10/1
• Rating change
  Barclays Maintains Braze(BRZE.US) With Buy Rating, Maintains Target Price $38
  Market Newswire · 2026/10/1
• Rating change
  Barclays Maintains Summit Therapeutics(SMMT.US) With Hold Rating, Raises Target Price to $20
  Market Newswire · 2026/10/1
• Company notice
  Coca-Cola | 8-K: Coca-Cola Company Entered into an Underwriting Agreement Among the Company and Citigroup Global Markets Inc., Barclays Capital Inc. And Santander Us Capital Markets LLC
  SEC · 2024/5/9
• Morgan Stanley reportedly poaches a key executive from Barclays to serve as Vice Chairman of its Technology Investment Banking division.
  Global Market Briefing · 2026/8/20
• Rating change
  Barclays Maintains McCormick & Co(MKC.US) With Hold Rating, Maintains Target Price $55
  Market Newswire · 2026/10/1
• Rating change
  Barclays Maintains Sutro Biopharma(STRO.US) With Buy Rating, Maintains Target Price $56
  Market Newswire · 2026/10/1
• Company notice
  OTS Holdings: General Announcement-Proposed acquisition by BCS Development Pte. Ltd.
  SGX · 2026/9/8
• Barclays PLC increased its stake in Dongjiang Environmental by 12.7888 million shares at approximately HK$1.93 per share.
  Sina Hong Kong Stocks · 2026/9/30
• Rating change
  Barclays Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36
  Market Newswire · 2026/10/1
• Company notice
  Barclays | SC 13G: Statement of acquisition of beneficial ownership by individuals-Barclays PLC(5.72%),Barclays Capital Inc.(5.64%), etc.
  SEC · 2024/2/17
• Correct: Barclays Group 2Q Net Interest Income GBP3.92B
  Dow Jones · 7/28
• U.S. Stocks Move | Barclays falls 5.6% in pre-market trading despite a 31% year-over-year increase in Q2 profit, as costs and impairments surge
  Gelonghui Finance · 7/28
• Former Barclays CEO: The Clarity Act is really good for banks, and the largest and most successful banks will benefit from it.
  Breakings · 8/2
• RBC Trims Price Target on Barclays to GBP5.50 From GBP5.75, Keeps Outperform Rating
  MT Newswires · 7/29

Headlines are aggregated automatically and are not independently verified or edited by our team.